• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guérin.

作者信息

Meeks Joshua J, Sexton Wade J, Clark Peter E

机构信息

Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.

Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida.

出版信息

J Urol. 2022 Sep;208(3):526-527. doi: 10.1097/JU.0000000000002779. Epub 2022 May 13.

DOI:10.1097/JU.0000000000002779
PMID:35549526
Abstract
摘要

相似文献

1
Sequential Chemotherapy with Gemcitabine and Docetaxel: Breaking the Chains of bacillus Calmette-Guérin.
J Urol. 2022 Sep;208(3):526-527. doi: 10.1097/JU.0000000000002779. Epub 2022 May 13.
2
Re: Sequential Intravesical Gemcitabine and Docetaxel for Bacillus Calmette-Guérin-naïve High-risk Nonmuscle-invasive Bladder Cancer.回复：吉西他滨和多西他赛序贯膀胱内灌注治疗初治的卡介苗耐药高危非肌层浸润性膀胱癌
Eur Urol. 2022 Dec;82(6):659. doi: 10.1016/j.eururo.2022.08.024. Epub 2022 Sep 8.
3
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer.序贯膀胱内吉西他滨和多西他赛治疗卡介苗初治高危非肌层浸润性膀胱癌。
J Urol. 2022 Sep;208(3):589-599. doi: 10.1097/JU.0000000000002740. Epub 2022 Jul 27.
4
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.经膀胱内吉西他滨联合 1/3 剂量卡介苗灌注治疗对非肌层浸润性膀胱癌患者生活质量的影响：一项前瞻性、随机、Ⅱ期临床试验的结果。
J Urol. 2013 Sep;190(3):857-62. doi: 10.1016/j.juro.2013.03.097. Epub 2013 Mar 29.
5
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure.卡介苗治疗失败后的高危非肌肉浸润性膀胱癌行膀胱内吉西他滨灌注治疗。
J Urol. 2013 Nov;190(5):1686-91. doi: 10.1016/j.juro.2013.04.120. Epub 2013 May 7.
6
Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non-muscle-invasive bladder cancer: Pro.序贯吉西他滨联合多西他赛是卡介苗无反应性非肌层浸润性膀胱癌的标准二线膀胱内治疗方法：专家观点
Eur Urol Focus. 2022 Jul;8(4):1117-1120. doi: 10.1016/j.euf.2021.07.018. Epub 2021 Sep 27.
7
Intracavitary bacillus Calmette-Guérin for Superficial Bladder Tumors.腔内卡介苗治疗浅表性膀胱肿瘤。
J Urol. 2017 Feb;197(2S):S146-S147. doi: 10.1016/j.juro.2016.10.083. Epub 2016 Dec 20.
8
Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure.膀胱内注射吉西他滨用于卡介苗治疗失败的高危浅表性膀胱移行细胞癌患者的初步经验。
Urol Nurs. 2014 Mar-Apr;34(2):95-9.
9
A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guérin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder.卡巴他赛、吉西他滨和顺铂膀胱内灌注治疗卡介苗无反应或复发性/转移性非肌肉浸润性膀胱癌的 I 期临床试验。
J Urol. 2020 Aug;204(2):247-253. doi: 10.1097/JU.0000000000000919. Epub 2020 Mar 2.
10
Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis.序贯膀胱内注射吉西他滨-多西他赛与卡介苗（BCG）治疗非肌层浸润性膀胱癌的初步成本效益分析
Urol Oncol. 2023 Sep;41(9):391.e1-391.e4. doi: 10.1016/j.urolonc.2023.04.005. Epub 2023 Apr 29.